1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Patient Referral Management Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Patient Referral Management Software Market, by Type / Referral Workflow Type
8.1.1 Inbound Referrals
8.1.1.1. Market Revenue and Forecast
8.1.2. Outbound Referrals
8.1.2.1. Market Revenue and Forecast
9.1. Patient Referral Management Software Market, by Component
9.1.1. Software
9.1.1.1. Market Revenue and Forecast
9.1.2. Services (Implementation, Training, Support)
9.1.2.1. Market Revenue and Forecast
10.1. Patient Referral Management Software Market, by Deployment Mode
10.1.1. Consumer
10.1.1.1. Market Revenue and Forecast
10.1.2. On-Premise
10.1.2.1. Market Revenue and Forecast
10.1.3. Industrial
10.1.3.1. Market Revenue and Forecast
10.1.4. Hybrid
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.1.2. Market Revenue and Forecast, by Component
11.1.3. Market Revenue and Forecast, by Deployment Mode
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.1.4.2. Market Revenue and Forecast, by Component
11.1.4.3. Market Revenue and Forecast, by Deployment Mode
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.1.5.2. Market Revenue and Forecast, by Component
11.1.5.3. Market Revenue and Forecast, by Deployment Mode
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.2.2. Market Revenue and Forecast, by Component
11.2.3. Market Revenue and Forecast, by Deployment Mode
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.2.4.2. Market Revenue and Forecast, by Component
11.2.4.3. Market Revenue and Forecast, by Deployment Mode
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.2.5.2. Market Revenue and Forecast, by Component
11.2.5.3. Market Revenue and Forecast, by Deployment Mode
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.2.6.2. Market Revenue and Forecast, by Component
11.2.6.3. Market Revenue and Forecast, by Deployment Mode
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.2.7.2. Market Revenue and Forecast, by Component
11.2.7.3. Market Revenue and Forecast, by Deployment Mode
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.3.2. Market Revenue and Forecast, by Component
11.3.3. Market Revenue and Forecast, by Deployment Mode
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.3.4.2. Market Revenue and Forecast, by Component
11.3.4.3. Market Revenue and Forecast, by Deployment Mode
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.3.5.2. Market Revenue and Forecast, by Component
11.3.5.3. Market Revenue and Forecast, by Deployment Mode
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.3.6.2. Market Revenue and Forecast, by Component
11.3.6.3. Market Revenue and Forecast, by Deployment Mode
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.3.7.2. Market Revenue and Forecast, by Component
11.3.7.3. Market Revenue and Forecast, by Deployment Mode
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.4.2. Market Revenue and Forecast, by Component
11.4.3. Market Revenue and Forecast, by Deployment Mode
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.4.4.2. Market Revenue and Forecast, by Component
11.4.4.3. Market Revenue and Forecast, by Deployment Mode
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.4.5.2. Market Revenue and Forecast, by Component
11.4.5.3. Market Revenue and Forecast, by Deployment Mode
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.4.6.2. Market Revenue and Forecast, by Component
11.4.6.3. Market Revenue and Forecast, by Deployment Mode
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.4.7.2. Market Revenue and Forecast, by Component
11.4.7.3. Market Revenue and Forecast, by Deployment Mode
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.5.2. Market Revenue and Forecast, by Component
11.5.3. Market Revenue and Forecast, by Deployment Mode
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.5.4.2. Market Revenue and Forecast, by Component
11.5.4.3. Market Revenue and Forecast, by Deployment Mode
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type / Referral Workflow Type
11.5.5.2. Market Revenue and Forecast, by Component
11.5.5.3. Market Revenue and Forecast, by Deployment Mode
12.1. Epic Systems Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cerner Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Allscripts Healthcare Solutions
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. McKesson Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. eClinicalWorks
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Athenahealth
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NextGen Healthcare
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. GE Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Philips Healthcare
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Greenway Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
